
RevOpsis Appoints Ronil Patel as Chief Business Officer
RevOpsis Therapeutics, a pioneering biopharmaceutical firm at the forefront of developing advanced ophthalmic therapies, has named Ronil Patel as its new Chief Business Officer. Patel brings over 15 years of extensive experience in biotechnology and global business development to his role, effective immediately. In his new capacity, Patel will steer RevOpsis’ global strategy and spearhead…